Following the previous major update and an all-time sales record in 2024, ImmuniWeb is delighted to announce a set of new features and improvements for all 6 products available on our award-winning Platform.

At ImmuniWeb, continuous innovation and continuous improvement are among our key priorities to help our customers and partners from over 50 countries to stay ahead of the rapidly evolving cyber threat landscape, meet regulatory requirements and prevent data breaches:

ImmuniWeb® Discovery:

New dashboard type: Statistics and Charts
New dashboard type: Software Bill of Materials (SBOM)
New dashboard type: My Recent Alerts and Notifications
Unified all-in-one popup to manage any asset or incident
Separation of compliance risk and CVSS-based security risk
Improved third-party incident detection (approx. 30% increase)
Improved squatting domains detection (approx. 30% increase)
Improved phishing websites detection (approx. 30% increase)
Improved risk and alert management and customization
Increased flexibility of automated asset classification
Additional data on vulnerable network software
Availability of some PDF reports via the API
New privacy test for all web assets
OSS ratings for network software
New graphs and charts in all tabs
ImmuniWeb® Neuron:

Introduction of one-time scan license (unlimited scans for 30 days)
New AI models for automation of additional OWASP ASVS L1/L2 requirements
Unified all-in-one pop up to manage and monitor any scan
Additional testing for client-side vulnerabilities in JS code
Better detection of privacy issues and misconfigurations
Detection of all web-related issues under PCI DSS 4.0
Supplementary authentications modes and regimes
Option to manage and customize risks manually
Additional DevSecOps and CI/CD integrations
ImmuniWeb® Neuron Mobile:

New AI models for automation of additional OWASP MASVS L1/L2 requirements
Detection of potentially suspicious or harmful mobile app activities
Unified all-in-one pop up to manage and monitor any scan
Additional detail on vulnerability exploitation techniques
Enhanced detection of privacy and third-party risks
Option to manage and customize risks manually
Additional DevSecOps and CI/CD integrations
ImmuniWeb® On-Demand and MobileSuite:

Testing for specific MITRE ATT&CK® TTPs (web, mobile & cloud) in Ultimate package
Increased speed of automated testing of all OWASP ASVS & MASVS requirements
Introduction of new AI models for advanced testing of Flutter-based web apps
Additional detail on advanced vulnerability exploitation techniques
Improved and enriched logs of penetration testing
ImmuniWeb® Continuous:

Option to manage and customize testing of scanning targets
New authentications modes and regimes for scanning targets
Individual testing statistics for each penetration testing and scanning target
Faster crawling and fuzzing subject to target availability (approx. 30% increase)
New AI models to better bypass WAF and provide working exploits
Improved and enriched logs of penetration testing
Improved Software Composition Analysis (SCA)
These and many other features and functionalities will be available to all users by the end of the day on March 31, 2025 at the very latest – at no extra cost – subject to their products, subscriptions and packages.

We invite all our clients and partners to review User Manuals available on the ImmuniWeb® Portal for each product to ensure that they leverage the full power of ImmuniWeb® AI Platform, as well as to register for upcoming product training webinars.

Dr. Ilia Kolochenko, Chief Architect & CEO at ImmuniWeb, says: “At ImmuniWeb, we are firmly committed to continually deliver value and technical excellence to all our customers and partners from over 50 countries.

Continuous improvement of our products ensures that we keep pace with the daily evolution of technology and the growing complexity of cyber threats amid the unprecedented geopolitical uncertainty around the globe.

Our incredible ImmuniWeb team works really hard around the clock to relentlessly innovate. We are delighted to see a solid and ongoing validation of our efforts by the steadily growing number of international awards and recognitions.

Full credit for our unstoppable success goes to everyone in our amazing team. Even more exciting updates and new products are coming very soon, please stay tuned.”

https://www.immuniweb.com/news/q1-2025-platform-update.html